**Core Concept**
Refractory ascites is a complication of advanced liver disease, characterized by persistent and recurrent ascites despite optimal medical therapy. The treatment of refractory ascites aims to improve quality of life by reducing ascitic fluid accumulation and associated complications.

**Why the Correct Answer is Right**
TIPSS (Transjugular Intrahepatic Portosystemic Shunt) is the most effective treatment for refractory ascites. It involves the creation of a shunt between the hepatic vein and the portal vein, reducing portal hypertension and subsequent ascitic fluid accumulation. TIPSS achieves this by decreasing the pressure gradient across the liver, thereby reducing the amount of fluid leaking into the peritoneal cavity.

**Why Each Wrong Option is Incorrect**
**Option A:** Diuretics are often used as first-line therapy for ascites, but they are ineffective in refractory ascites, where the liver's ability to produce diuretic hormones is impaired.
**Option B:** Large-volume paracentesis is a temporary measure for relief, but it does not address the underlying cause of ascites and may lead to complications like infection and electrolyte imbalances.
**Option C:** Liver transplantation is the ultimate solution for end-stage liver disease but is not a viable option for refractory ascites alone, as it requires comprehensive evaluation and prioritization based on overall liver function and other comorbidities.

**Clinical Pearl / High-Yield Fact**
TIPSS is generally considered in patients with refractory ascites who have failed to respond to diuretics and large-volume paracentesis, and have a Child-Pugh score of 9 or higher.

**Correct Answer: TIPSS. Transjugular Intrahepatic Portosystemic Shunt.**